DNA President and CEO Dr. Liang Elected to RPA Board

Effective March 17, 2021, Dallas Nephrology Associates President and CEO Alexander Liang, M.D. will be elected to the Board of Directors of the Renal Physicians Association. 

Dr. Liang has been involved with the RPA for several years, including his contribution of several papers and lectures at annual meetings.

“It is such an honor to have the opportunity to serve on the board of this amazing organization that is truly dedicated to furthering the practice of nephrology,” Dr. Liang says. “I look forward to joining the great group of kidney specialists on the board as we help guide the direction of RPA.” 

Since 1973, the Renal Physicians Association (RPA) has been dedicated to representing and serving nephrology practitioners in their pursuit and delivery of quality renal health care. 

RPA is a non-profit 501c6 national nephrology specialty medical association.  It has grown to more than 3,500 members serving kidney patients nationwide. Members are devoted to improving the care of patients with kidney disease and related disorders.